연구성과로 돌아가기
2020 연구성과 (151 / 270)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| WoS | SCOPUS | Document Type | Document Title | Abstract | Authors | Affiliation | ResearcherID (WoS) | AuthorsID (SCOPUS) | Author Email(s) | Journal Name | JCR Abbreviation | ISSN | eISSN | Volume | Issue | WoS Edition | WoS Category | JCR Year | IF | JCR (%) | FWCI | FWCI Update Date | WoS Citation | SCOPUS Citation | Keywords (WoS) | KeywordsPlus (WoS) | Keywords (SCOPUS) | KeywordsPlus (SCOPUS) | Language | Publication Stage | Publication Year | Publication Date | DOI | JCR Link | DOI Link | WOS Link | SCOPUS Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ○ | ○ | Article | Derivatives of normal Jacobi operator on real hypersurfaces in the complex quadric | Suh (Math. Nachr. 290 (2017) 442-451) proved that there are no Hopf real hypersurfaces in the complex quadric that have parallel normal Jacobi operators. Motivated by this result, in this paper, we introduce the notions ofC-parallelandReeb parallelfor normal Jacobi operators, which generalize the notion 'parallel'. First we obtain a non-existence theorem of Hopf real hypersurfaces withC-parallel normal Jacobi operator in the complex quadricQmform > 3. We then prove that a Hopf real hypersurface has a Reeb parallel normal Jacobi operator if and only if it has anA-isotropic singular normal vector field. | Lee, Hyunjin; Perez, Juan de Dios; Suh, Young Jin | Kyungpook Natl Univ, Res Inst Real & Complex Manifolds RIRCM, Daegu 41566, South Korea; Univ Granada, Dept Geometria & Topol, Campus Fuentenueva S-N, Granada 18071, Spain; Univ Granada, IEMATH, Campus Fuentenueva S-N, Granada 18071, Spain; Kyungpook Natl Univ, Dept Math, Daegu 41566, South Korea | de Dios Perez, Juan/B-7768-2015 | 55706812200; 57205268627; 7202260479 | lhjibis@hanmail.net;jdperez@ugr.es;yjsuh@knu.ac.kr; | BULLETIN OF THE LONDON MATHEMATICAL SOCIETY | B LOND MATH SOC | 0024-6093 | 1469-2120 | 52 | 6 | SCIE | MATHEMATICS | 2020 | 1.034 | 44.1 | 1.38 | 2025-06-25 | 9 | 9 | 53C40 (primary); 53C55 (secondary) | EINSTEIN HYPERSURFACES; CONTACT HYPERSURFACES; 2-PLANE GRASSMANNIANS | 53C40 (primary); 53C55 (secondary) | English | 2020 | 2020-12 | 10.1112/blms.12386 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | A Comparative Study of Carabid Beetles in Green Spaces and Former Natural Habitats | Urban expansion threatens ecosystems through direct habitat conversion. To secure urban biodiversity and enhance ecosystem services, a common focus of planning and growth management efforts is to establish green spaces. This study aimed to understand the formation process of newly created green spaces after urban development. We investigated the carabid beetle assemblages in its current habitat in a new city and in its former habitats for assessing the loss of species diversity by urban development and to identify the initial status of species assemblages in the current urban habitats, including green spaces. The diversity and composition of the carabid beetle assemblages significantly changed in the new city. The former habitat loss by urban development leaves large numbers of carabid species to dramatically decline. Carabid assemblages in current habitats may show a critical response to habitat loss, although former habitats were converted to green spaces. Some carabid species were only present in current habitats, including the green space from former habitats. In addition, the current habitat, including green spaces and other habitats, have similar carabid assemblages. Our results indicated that the loss of former habitat has a much greater effect on species diversity persistence than changes in habitat configuration and the creation of green spaces. Consequently, most carabid beetles were already lost during development. Urban habitats in new cities, including green spaces, represent simple and homogeneous habitats, although the development was designed and planned to enhance biodiversity. The present design and planning practice for green spaces that destroyed all former habitats to prepare the ground of urban areas and thereby created urban habitats, including green space, may need to be changed to secure biodiversity. Designing and planning the green spaces should consider the species' former habitats, for instance, creating a similar type of green space to agricultural land, forest, and wetland, and thereby the former habitat remains intact to enhance biodiversity and function. | Park, Yonghwan; Kim, Chang-Jun; Choi, Moon-Bo; Do, Yuno | Korea Natl Arboretum, Div Forest Biodivers, Pochon 11186, South Korea; Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu 41566, South Korea; Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu 41566, South Korea; Kongju Natl Univ, Dept Biol Sci, Gongju 32588, South Korea | KIm, Changjun/GZM-7308-2022 | 56601933000; 55286588300; 51863232400; 52163435800 | parkyonghwan@korea.kr;changjunkim@korea.kr;kosinchoi@hanmail.net;doy@kongju.ac.kr; | DIVERSITY-BASEL | DIVERSITY-BASEL | 1424-2818 | 12 | 12 | SCIE | BIODIVERSITY CONSERVATION;ECOLOGY | 2020 | 2.465 | 44.2 | 0 | 2025-06-25 | 1 | 4 | Carabidae; habitat loss; historic habitat; new city development; urbanization | ASSEMBLAGES COLEOPTERA; URBANIZATION GRADIENT; URBAN; BIODIVERSITY; FRAGMENTATION; MANAGEMENT; ECOSYSTEM; ECOLOGY; STRESS; CITIES | Carabidae; Habitat loss; Historic habitat; New city development; Urbanization | Carabidae; Coleoptera; beetle; biodiversity; community composition; comparative study; greenspace; habitat conservation; habitat loss; urban development; urbanization | English | 2020 | 2020-12 | 10.3390/d12120479 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Optimal Control Method for HVAC Systems in Offices with a Control Algorithm Based on Thermal Environment | This study examined a method to reduce energy consumption in office buildings. Correspondingly, an optimal control method was proposed for heating, ventilation, and air conditioning (HVAC) systems via two control algorithms that considered the indoor thermal environment. The control algorithms were developed by considering temperature and humidity as the factors of the indoor thermal environment that influence the control of HVAC systems and the predicted mean vote comfort ranges. Furthermore, an experiment was performed using office equipment that incorporated the two control algorithms for HVAC systems, and the correlation between changes in the thermal environment within the office and the occupant's comfort levels was estimated via an actual survey. The results demonstrated that the proposed control method for HVAC systems, which considered the comfort ranges of temperature and humidity and the thermal adaptation capability, can efficiently maintain the occupant's comfort with lower energy usage compared with conventional HVAC systems. Thus, the use of the control method contributes to the reduction of total energy consumption in buildings with HVAC systems. | Kim, Sung-Kyung; Hong, Won-Hwa; Hwang, Jung-Ha; Jung, Myung-Sup; Park, Yong-Seo | Kyungpook Natl Univ, Sch Architectural Civil Environm & Energy Engn, Daegu 41566, South Korea; Kyungpook Natl Univ, Dept Architectural, Daegu 41566, South Korea; Kyungpook Natl Univ, Sch Architecture, Daegu 41566, South Korea | Jung, Hee-Tae/C-1574-2011 | 57196459261; 7401527968; 55710714500; 57225689815; 57217080207 | kimsg1321@gmail.com;hongwh@knu.ac.kr;peter@knu.ac.kr;mschung36@knu.ac.kr;archipark@knu.ac.kr; | BUILDINGS | BUILDINGS-BASEL | 2075-5309 | 10 | 5 | SCIE | CONSTRUCTION & BUILDING TECHNOLOGY;ENGINEERING, CIVIL | 2020 | 2.648 | 44.2 | 0.71 | 2025-06-25 | 10 | 11 | HVAC system; optimal control method; temperature control; PMV control; comfort range; control algorithm; building; energy saving | ENERGY-CONSUMPTION; COMFORT; BUILDINGS; TEMPERATURE; PERFORMANCE; IMPACT; MODEL | Building; Comfort range; Control algorithm; Energy saving; HVAC system; Optimal control method; PMV control; Temperature control | English | 2020 | 2020-05 | 10.3390/buildings10050095 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Performance analysis of liquified petroleum gas (LPG) driven half-cycle air conditioning system | Liquified petroleum gas (LPG) is one of the potential refrigerants to be used in half-cycle air conditioning systems. After evaporation to get air-conditioning, LPG may be further used in combustion applications such as electric-generators, auto-motives and cooking stoves. Expansion device (or a flow control valve) is usually used before the evaporator to make sure that the refrigerant vaporizes in evaporator and provides cooling. The present study reports the investigation of an experimental study to determine the performance of three in-house designed and manufactured evaporators for an air conditioning system using LPG as refrigerant. The evaporators used are finned-tube evaporators having difference in tube arrangements, fin materials, fin spacing and tube dimensions. The thermal energy to evaporate LPG is obtained from air driven by a fan attached to one side of the evaporator. Cold air exiting from the evaporator is then supplied to a cabin having the similar dimensions of an automotive rickshaw. The performance parameters determined for a fixed time duration for different fan speeds include; the cooling effect, contact factor and rate of condensation. The investigations were conducted for different LPG flow rates and evaporative pressures. The test results show that for each flow condition; the cooling effect, contact factor and rate of condensation are also the function of air flow rate passing through the evaporator. Experimentally determined cooling effects were then analytically validated by using the Nusselt number correlations of Grimison model, modified Grimison model and Zhukauskas model for each of the evaporators used. | Muzaffar, Atif; Cheema, Taqi Ahmad; Abbas, Ahmad; Tayyab, Muhammad; Ilyas, Muhammad; Park, Cheol Woo | GIK Inst Engn Sci & Technol, Fac Mech Engn, Topi 23460, Pakistan; Kyungpook Natl Univ, Sch Mech Engn, 80 Daehak Ro, Daegu 41566, South Korea | Ilyas, Muhammad/ABB-4932-2020; Abbas, Ahmad/GSM-9364-2022 | 57218368861; 36522492600; 57193502684; 58793345200; 57718772400; 7408416474 | tacheema@giki.edu.pk;chwoopark@knu.ac.kr; | HEAT AND MASS TRANSFER | HEAT MASS TRANSFER | 0947-7411 | 1432-1181 | 56 | 12 | SCIE | MECHANICS;THERMODYNAMICS | 2020 | 2.464 | 44.2 | 0.61 | 2025-06-25 | 2 | 7 | HEAT-PUMP | Air conditioning; Condensation; Cooling; Evaporative cooling systems; Evaporators; Fins (heat exchange); Gasoline; Petroleum analysis; Refrigerants; Expansion devices; Finned-tube evaporators; Flow control valves; Nusselt number correlation; Performance analysis; Performance parameters; Rate of condensations; Tube arrangements; Liquefied petroleum gas | English | 2020 | 2020-12 | 10.1007/s00231-020-02898-7 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma | The current standard cisplatin regimen for concurrent chemoradiation therapy (CCRT) involves generalized static administration of cisplatin without considering patient characteristics and patient/tumor responses during treatment. We aimed to evaluate the oncological feasibility of individualized/dynamic cisplatin regimens for definitive CCRT in patients with head and neck squamous cell carcinoma (HNSCC). This prospective, single-center study enrolled patients with biopsy-confirmed HNSCC for whom CCRT was indicated as the primary treatment. Concurrent with radiation therapy (RT), patients received individualized and dynamically modified cisplatin chemotherapy based on patient characteristics, such as age and Eastern Cooperative Oncology Group performance status (PS), and patient/tumor treatment responses. The primary endpoints of the study were grade >= 3 toxicity and progression-free survival (PFS). The study enrolled 150 patients; 146 (97.3%) received >= 2 cycles of cisplatin in addition to scheduled RT. Incidence of any grade 3-4 toxicities was 40.7% (61/150). During the 40.1 +/- 25.1-month follow-up period, the 2-year locoregional control, distant control, PFS, disease-specific survival, and overall survival were 81.7%, 89.2%, 73.0%, 89.2%, and 86.1%, respectively. The treatment compliance and grade >= 3 toxicities did not differ between patients aged = 70 years, or those with PS 0 and PS 1-2, respectively. CCRT using individualized, dynamic cisplatin regimens based on patient age, PS, and patient/tumor responses during treatment was oncologically safe and effective for treating patients with HNSCC, including those aged >= 70 years and with PS 1-2. | Ahn, Dongbin; Lee, Gil Joon; Sohn, Jin Ho; Lee, Jeong Eun | Kyungpook Natl Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, Daegu, South Korea | 44761055400; 57193082568; 55165818100; 57206732333 | godlikeu@naver.com; | CANCER MEDICINE | CANCER MED-US | 2045-7634 | 9 | 24 | SCIE | ONCOLOGY | 2020 | 4.452 | 44.4 | 0.37 | 2025-06-25 | 5 | 5 | LOCALLY ADVANCED HEAD; PERFORMANCE STATUS; RADIATION-THERAPY; DOSE CISPLATIN; CANCER; CHEMOTHERAPY; CHEMORADIOTHERAPY; RADIOTHERAPY | chemoradiotherapy; cisplatin; head and neck squamous cell carcinoma; performance status; protocol; toxicity | Aged; Aged, 80 and over; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Precision Medicine; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; cisplatin; antineoplastic agent; cisplatin; aged; anemia; Article; cancer radiotherapy; chemoradiotherapy; controlled clinical trial; controlled study; disease specific survival; feasibility study; febrile neutropenia; female; head and neck squamous cell carcinoma; human; human cell; leukopenia; male; mucosa inflammation; multiple cycle treatment; nausea; nephrotoxicity; overall survival; phase 2 clinical trial; priority journal; progression free survival; prospective study; radiation dermatitis; thrombocytopenia; treatment response; vomiting; chemoradiotherapy; clinical trial; dose response; head and neck tumor; middle aged; pathology; personalized medicine; procedures; survival rate; very elderly | English | 2020 | 2020-12 | 10.1002/cam4.3529 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||||
| ○ | ○ | Article | Robust test for dispersion parameter change in discretely observed diffusion processes | This paper deals with the problem of testing for dispersion parameter change in discretely observed diffusion processes when the observations are contaminated by outliers. To lessen the impact of outliers, we first calculate residuals using a robust estimate and then propose a trimmed-residual based CUSUM test. The proposed test is shown to converge weakly to a function of the Brownian bridge under the null hypothesis of no parameter change. We conduct simulations to evaluate performances of the proposed test in the presence of outliers. Numerical results confirm that the proposed test possesses a strong robust property against outliers. In real data analysis, we fit the Ornstein-Uhlenbeck process to KOSPI200 volatility index data and locate some change points that are not detected by a naive CUSUM test. (C) 2019 Elsevier B.V. All rights reserved. | Song, Junmo | Kyungpook Natl Univ, Dept Stat, 80 Daehakro, Daegu 41566, South Korea | 23470710200 | jsong@knu.ac.kr; | COMPUTATIONAL STATISTICS & DATA ANALYSIS | COMPUT STAT DATA AN | 0167-9473 | 1872-7352 | 142 | SCIE | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;STATISTICS & PROBABILITY | 2020 | 1.681 | 44.4 | 0.8 | 2025-06-25 | 8 | 9 | Diffusion processes; Parameter change test; Outliers; Trimmed-residual based test; Robust test | MAXIMUM-LIKELIHOOD-ESTIMATION; POWER DIVERGENCE ESTIMATOR; ERGODIC DIFFUSION; MODEL | Diffusion processes; Outliers; Parameter change test; Robust test; Trimmed-residual based test | Diffusion; Statistics; Diffusion process; Dispersion parameters; Numerical results; Outliers; Parameter changes; Real data analysis; Robust tests; Volatility index; Dispersions | English | 2020 | 2020-02 | 10.1016/j.csda.2019.106832 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Efficacy and pharmacokinetics evaluation of 4-(2-chloro-4-fluorobenzyl)-3-(2-thienyl)-1,2,4-oxadiazol-5(4H)-one (GM-90432) as an anti-seizure agent | Epilepsy is a common chronic neurological disease characterized by recurrent epileptic seizures. A seizure is an uncontrolled electrical activity in the brain that can cause different levels of behavior, emotion, and consciousness. One-third of patients fail to receive sufficient seizure control, even though more than fifty FDA-approved anti-seizure drugs (ASDs) are available. In this study, we attempted small molecule screening to identify potential therapeutic agents for the treatment of seizures using seizure-induced animal models. Through behavioral phenotype-based screening, 4-(2-chloro-4-fluorobenzyl)-3-(2-thienyl)-1,2,4-oxadiazol-5(4H)-one (GM-90432) was identified as a prototype. GM-90432 treatment effectively decreased seizure-like behaviors in zebrafish and mice with chemically induced seizures. These results were consistent with decreased neuronal activity through immunohistochemistry for pERK in zebrafish larvae. Additionally, electroencephalogram (EEG) analysis revealed that GM-90432 decreases seizure-specific EEG events in adult zebrafish. Moreover, we revealed the preferential binding of GM-90432 to voltage-gated Na+ channels using a whole-cell patch clamp technique. Through pharmacokinetic analysis, GM-90432 effectively penetrated the blood-brain barrier and was distributed into the brain. Taken together, we suggest that GM-90432 has the potential to be developed into a new ASD candidate. | Hwang, Kyu-Seok; Kan, Hyemin; Kim, Seong Soon; Chae, Jin Sil; Yang, Jung Yoon; Shin, Dae-Seop; Ahn, Se Hwan; Ahn, Jin Hee; Cho, Jin-Hwa; Jang, Il-Sung; Shin, Junnyeong; Joo, Jaeyoung; Kim, Cheol-Hee; Bae, Myung Ae | Korea Res Inst Chem Technol, Drug Discovery Platform Res Ctr, Daejeon 34114, South Korea; Gwangju Inst Sci & Technol, Dept Chem, Gwangju 61005, South Korea; Kyungpook Natl Univ, Sch Dent, Dept Pharmacol, Daegu 41940, South Korea; Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu 41940, South Korea; Zefit Inc, Daegu 42988, South Korea; Daegu Gyeongbuk Inst Sci & Technol, Sch Undergrad Studies, Daegu 41940, South Korea; Chungnam Natl Univ, Dept Biol, Daejeon 34114, South Korea | Ahn, Jin/C-6122-2019; Kim, Seong Soon/IZE-2538-2023; Kim, Cheol-Hee/F-6278-2013 | 57206977618; 57205624645; 57194944619; 57194943197; 57194946980; 55510490000; 57205629337; 56714432600; 24167566000; 7102177910; 57219391155; 57219375745; 16245115100; 7005711682 | mbae@krict.re.kr; | NEUROCHEMISTRY INTERNATIONAL | NEUROCHEM INT | 0197-0186 | 1872-9754 | 141 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY;NEUROSCIENCES | 2020 | 3.921 | 44.5 | 0.32 | 2025-06-25 | 8 | 7 | Zebrafish; Anti-seizure drug; Electroencephalogram; Electrophysiology; Pharmacokinetics | BLOOD-BRAIN-BARRIER; SODIUM-CHANNELS; ZEBRAFISH; EPILEPSY; CARBAMAZEPINE; LACOSAMIDE; PHENYTOIN; BEHAVIOR; MODELS; DRUGS | Anti-seizure drug; Electroencephalogram; Electrophysiology; Pharmacokinetics; Zebrafish | Animals; Anticonvulsants; Behavior, Animal; Blood-Brain Barrier; Electroencephalography; Immunohistochemistry; Larva; Male; MAP Kinase Signaling System; Mass Screening; Mice; Mice, Inbred ICR; Oxadiazoles; Patch-Clamp Techniques; Seizures; Small Molecule Libraries; Sodium Channels; Zebrafish; 4 (2 chloro 4 fluorobenzyl) 3 (2 thienyl) 1,2,4 oxadiazol 5(4h) one; anticonvulsive agent; gm 90432; pentetrazole; unclassified drug; voltage gated sodium channel; anticonvulsive agent; GM-90432; oxadiazole derivative; sodium channel; animal experiment; animal model; animal tissue; anticonvulsant activity; area under the curve; Article; blood brain barrier; drug distribution; drug efficacy; drug penetration; drug screening; electroencephalogram; electrophysiology; epilepsy; female; hippocampus; immunohistochemistry; male; maximum concentration; mouse; nonhuman; pharmacokinetics; phenotype; priority journal; pyramidal nerve cell; time to maximum plasma concentration; whole cell patch clamp; zebra fish; animal; animal behavior; drug effect; electroencephalography; Institute for Cancer Research mouse; larva; MAPK signaling; mass screening; metabolism; molecular library; patch clamp technique; psychology; seizure | English | 2020 | 2020-12 | 10.1016/j.neuint.2020.104870 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Alpha-Gal and Cross-Reactive Carbohydrate Determinants in the N-Glycans of Salivary Glands in the Lone Star Tick, Amblyomma americanum | Ticks are important ectoparasites and vectors of numerous human and animal pathogens. Ticks secrete saliva that contains various bioactive materials to evade the host defense system, and often facilitates the pathogen transmission. In addition, the Lone star tick saliva is thought to be the sensitizer in red meat allergy that is characterized by an allergic reaction to glycan moieties carrying terminal galactose-alpha-1,3-galactose (aGal). To assess N-glycome of Amblyomma americanum, we examined the N-glycan structures in male and female salivary glands at three different feeding stages and in carcasses of partially fed lone star ticks. We also surveyed the genes involved in the N-glycosylation in the tick species. The aGal epitopes and cross-reactive carbohydrate determinants (CCD) increases over time after the onset of blood feeding in both male and female A. americanum. These CCDs include xylosylation of the core mannose, 1,3-mono and 1,3- and 1,6-difucosylations of the basal GlcNac and mono- or diantennary aGal. Combinations of both xylosylation and aGal and fucosylation and aGal were also found on the N-glycan structures. While the enzymes required for the early steps of the N-glycosylation pathway are quite conserved, the enzymes involved in the later stages of N-glycan maturation in the Golgi apparatus are highly diverged from those of insects. Most of all, we propose that the aGal serves as a molecular mimicry of bioactive proteins during tick feedings on mammalian hosts, while it contributes as a sensitizer of allergy in atypical host human. | Park, Yoonseong; Kim, Donghun; Boorgula, Gunavanthi D.; De Schutter, Kristof; Smagghe, Guy; Simo, Ladislav; Archer-Hartmann, Stephanie A.; Azadi, Parastoo | Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; Kyungpook Natl Univ, Dept Appl Biol, Sangju 37224, Gyeongbuk, South Korea; Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Coupure Links 653, Ghent 9000, Belgium; Univ Paris Est, ANSES, Ecole Natl Vet Alfort, UMR BIPAR,INRAE, Maisons Alfort 94700, France; Univ Georgia, Complex Carbohydrate Ctr, Athens, GA 30602 USA | De Schutter, Kristof/E-5400-2018; Park, Yoonseong/J-5861-2013; Smagghe, Guy/AAE-8914-2019 | 7405370790; 56115927500; 57202926951; 26647349700; 7005189561; 16043564100; 21741998000; 56758820600 | ypark@ksu.edu;dklome2018@knu.ac.kr;boorgulagd@ksu.edu;kristof.deschutter@ugent.be;Guy.Smagghe@UGent.be;ladislay.simo@vet-alfort.fr;sarcher@ccrc.uga.edu;azadi@ccrc.uga.edu; | VACCINES | VACCINES-BASEL | 2076-393X | 8 | 1 | SCIE | IMMUNOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL | 2020 | 4.422 | 44.6 | 1.85 | 2025-06-25 | 28 | 29 | alpha-gal; red meat allergy; glygosylation; xylosylation; molecular mimicry; glycan | RED MEAT ALLERGY; MOLECULAR MIMICRY; BINDING PROTEINS; IGE; HOST; TRYPANOSOMA; ASSOCIATION; ANTIBODY; XENOTRANSPLANTATION; OLIGOSACCHARIDE | Alpha-gal; Glycan; Glygosylation; Molecular mimicry; Red meat allergy; Xylosylation | epitope; galactosylgalactose; glycan; adult; Amblyomma americanum; animal experiment; Article; carbohydrate analysis; carcass; cross reaction; female; fucosylation; immune evasion; male; molecular mimicry; nonhuman; protein glycosylation; salivary gland; sensitization | English | 2020 | 2020-03 | 10.3390/vaccines8010018 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Efficient Removal of Non-Structural Protein Using Chloroform for Foot-and-Mouth Disease Vaccine Production | To differentiate foot-and-mouth disease (FMD)-infected animals from vaccinated livestock, non-structural proteins (NSPs) must be removed during the FMD vaccine manufacturing process. Currently, NSPs cannot be selectively removed from FMD virus (FMDV) culture supernatant. Therefore, polyethylene glycol (PEG) is utilized to partially separate FMDV from NSPs. However, some NSPs remain in the FMD vaccine, which after repeated immunization, may elicit NSP antibodies in some livestock. To address this drawback, chloroform at a concentration of more than 2% (v/v) was found to remove NSP efficiently without damaging the FMDV particles. Contrary to the PEG-treated vaccine that showed positive NSP antibody responses after the third immunization in goats, the chloroform-treated vaccine did not induce NSP antibodies. In addition to this enhanced vaccine purity, this new method using chloroform could maximize antigen recovery and the vaccine production time could be shortened by two days due to omission of the PEG processing phase. To our knowledge, this is the first report to remove NSPs from FMDV culture supernatant by chemical addition. This novel method could revolutionize the conventional processes of FMD vaccine production. | Park, Sun Young; Lee, Jung-Min; Kim, Ah-Young; Park, Sang Hyun; Lee, Sim-In; Kim, Hyejin; Kim, Jae-Seok; Park, Jong-Hyeon; Ko, Young-Joon; Park, Choi-Kyu | Anim & Plant Quarantine Agcy, Gimcheon Si 39660, South Korea; Kyungpook Natl Univ, Coll Vet Med, Anim Dis Intervent Ctr, Daegu 41566, South Korea | ; Park, Sun-Young/B-4634-2014 | 55616559900; 57196483573; 7402063210; 57219557904; 57215039741; 58369688700; 56106886000; 55717103700; 35068343300; 24768064900 | sun3730@korea.kr;wjdalslee@korea.kr;mochsha@korea.kr;shpark0205@korea.kr;lunark2@korea.kr;hyejin86j@korea.kr;kimjs0728@korea.kr;parkjhvet@korea.kr;koyoungjoon@korea.kr;parkck@knu.ac.kr; | VACCINES | VACCINES-BASEL | 2076-393X | 8 | 3 | SCIE | IMMUNOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL | 2020 | 4.422 | 44.6 | 0.4 | 2025-06-25 | 7 | 9 | foot-and-mouth disease virus; inactivated vaccine; non-structural protein; purity; chloroform | VIRUS; PURIFICATION; ELISA; STEP; 3ABC | Chloroform; Foot-and-mouth disease virus; Inactivated vaccine; Non-structural protein; Purity | chloroform; foot and mouth disease vaccine; viral nonstructural protein; animal cell; antibody response; Article; BHK-21 cell line; cell suspension; enzyme linked immunosorbent assay; foot and mouth disease; Foot and mouth disease virus; nonhuman; vaccination; vaccine production; virus neutralization; virus titration; Western blotting | English | 2020 | 2020-09 | 10.3390/vaccines8030483 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Pelargonidin ameliorates acetaminophen-induced hepatotoxicity in mice by inhibiting the ROS-induced inflammatory apoptotic response | The common analgesic acetaminophen (N-acetyl-p-aminophenol, APAP) is non-toxic to the liver at therapeutic doses. However, an overdose of APAP can lead to APAP-induced liver failure, which has emerged as a serious issue in the US and Europe. Pelargonidin is an anthocyanidin found in pomegranates, plums, and various berries. Pelargonidin has strong antioxidant effects, directly scavenging superoxide radicals and inhibiting H2O2-induced lipid peroxidation. Focusing on these effects, we studied the preventative effect of pelargonidin on APAP-induced hepatotoxicity and its underlying mechanisms in vivo. We observed that pelargonidin mitigates serum alanine aminotransferase and aspartate aminotransferase activity, which are strongly associated with APAP-induced hepatotoxicity. We also found that pelargonidin reduced APAP-induced hepatic necrosis by removing excessive ROS. Hepatic necrosis stimulates the release of molecular pathogens that induce inflammation, which increases cell stress and can lead to apoptosis. Therefore, pelargonidin was able to reduce levels of necrosis, inflammation, and hepatocyte apoptosis. These results indicate that the administration of pelargonidin protects against APAP-induced hepatotoxicity and that it could be a novel protective strategy against APAP-induced liver failure. (C) 2019 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved. | Seo, Minseok; Kim, Hyunjin; Lee, Jin Hyup; Park, Jeen-Woo | Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, BK21 Plus KNU Creat BioRes Grp, Taegu, South Korea; Korea Univ, Dept Food & Biotechnol, Sejong, South Korea | park, jun yeon/GPX-5293-2022 | 57211608409; 57206212088; 36067819400; 35574514000 | parkjw@knu.ac.kr; | BIOCHIMIE | BIOCHIMIE | 0300-9084 | 1638-6183 | 168 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 2020 | 4.079 | 44.6 | 0.68 | 2025-06-25 | 13 | 13 | Pelargonidin; Acetaminophen; Liver failure; Inflammation; Apoptosis | REACTIVE OXYGEN; ERK ACTIVATION; LIVER-INJURY; CELL-DEATH; KINASE; ANTIOXIDANT; MACROPHAGES; PATHWAYS; RELEASE; PROTEIN | Acetaminophen; Apoptosis; Inflammation; Liver failure; Pelargonidin | Acetaminophen; Alanine Transaminase; Animals; Anthocyanins; Antioxidants; Apoptosis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; alanine aminotransferase; aspartate aminotransferase; hydrogen peroxide; paracetamol; pelargonidin; reactive oxygen metabolite; superoxide; alanine aminotransferase; anthocyanin; antioxidant; aspartate aminotransferase; paracetamol; pelargonidin; protective agent; alanine aminotransferase blood level; animal experiment; animal model; animal tissue; antioxidant activity; apoptosis; Article; aspartate aminotransferase blood level; berry; cell stress; inflammation; lipid peroxidation; liver failure; liver necrosis; liver tissue; liver toxicity; mouse; nonhuman; plum; pomegranate; animal; C57BL mouse; drug effect; liver; male; metabolism; oxidative stress; pathology; toxic hepatitis | English | 2020 | 2020-01 | 10.1016/j.biochi.2019.10.009 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | Article | The effect of high dose intravenous Vitamin C during radiotherapy on breast cancer patients’ neutrophil–lymphocyte ratio | Background: Breast cancer is very common, and the incidence is growing every year. Most breast cancers are treated with radiation after surgery. As a side effect of radiation therapy, inflammation, as well as the neutrophil–lymphocyte ratio (NLR), level increases. However, high NLR levels act as independent prognostic factors for increased mortality in all cancers. In this study, the authors investigated whether administration of vitamin C, which is effective in suppressing inflammation, may help to reduce high levels of NLR produced by radiation therapy. Methods: This study was performed retrospectively among 424 patients who were diagnosed with breast cancer and were treated with postoperative radiotherapy at Kosin University Gospel Hospital from January 2011 to December 2017. Among them, 354 patients received radiation therapy without vitamin C (the control group), and 70 experimental patients received vitamin C intravenously twice a week for at least 4 weeks during radiation therapy. The experimental group was divided into two groups according to the dose administrated: a low-dose vitamin C group (less than 1 g/kg, 52 patients) and a high-dose vitamin C group (more than 1 g/kg, 18 patients). The authors conducted three NLR measurements: before and after radiation therapy and at 3 months after radiation therapy; the authors then compared the change in NLR over time between the groups using repeated measures analysis of variance. Results: In the control group and the low-dose vitamin C-administered group, NLR was increased at the endpoint compared to before the radiotherapy, whereas NLR values in the high-dose vitamin C group were 8.4 – 1.7, 5.9 – 1.3, and 4.3 – 1.5, showing a continuous decrease and a statistically significant difference (pinteraction = 0.033). These results were similarly observed in models adjusted by the patient’s age and American Joint Committee on Cancer stage, with borderline significance (pinteraction = 0.065). Conclusions: Elevated NLR, a measure of systemic inflammation, has been associated with higher mortality cancer patients, including breast cancer patients. In this observational study, NLR was significantly decreased during radiation therapy in patients administered high-dose vitamin C. © Mary Ann Liebert, Inc. | Park, Hyunwoo; Kang, Jihun; Choi, Jongsoon; Heo, Somi; Lee, Duk-Hee | Department of Family Medicine, Kosin University Gospel Hospital, Kosin University, College of Medicine, 262, Gamcheon-ro,, Seo-gu Busan, 49267, South Korea; Department of Family Medicine, Kosin University Gospel Hospital, Kosin University, College of Medicine, 262, Gamcheon-ro,, Seo-gu Busan, 49267, South Korea; Department of Family Medicine, Kosin University Gospel Hospital, Kosin University, College of Medicine, 262, Gamcheon-ro,, Seo-gu Busan, 49267, South Korea; Department of Preventive Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Preventive Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea | 57219971284; 59849983100; 56126609100; 57204934087; 57211851121 | fmcjs@naver.com; | Journal of Alternative and Complementary Medicine | J ALTERN COMPLEM MED | 1075-5535 | 1557-7708 | 26 | 11 | SCIE | INTEGRATIVE & COMPLEMENTARY MEDICINE | 2020 | 2.582 | 44.6 | 0.42 | 2025-06-25 | 5 | Breast cancer; High-dose vitamin C; Neutrophil–lymphocyte ratio; Radiotherapy | Antineoplastic Agents; Antioxidants; Ascorbic Acid; Breast Neoplasms; Female; Humans; Lymphocytes; Middle Aged; Neutrophils; Retrospective Studies; Time Factors; Treatment Outcome; ascorbic acid; antineoplastic agent; antioxidant; ascorbic acid; adult; age; Article; breast cancer; cancer patient; cancer prognosis; cancer radiotherapy; controlled study; data analysis software; dose response; drug dose comparison; drug effect; drug megadose; female; human; low drug dose; major clinical study; middle aged; mortality; neutrophil lymphocyte ratio; postoperative period; priority journal; retrospective study; treatment duration; breast tumor; drug effect; lymphocyte; neutrophil; pathology; time factor; treatment outcome | English | Final | 2020 | 10.1089/acm.2020.0138 | 바로가기 | 바로가기 | 바로가기 | |||||||
| ○ | ○ | Article | Measurement of the integrated luminosity of the Phase 2 data of the Belle II experiment | From April to July 2018, a data sample at the peak energy of the resonance was collected with the Belle II detector at the SuperKEKB electron-positron collider. This is the first data sample of the Belle II experiment. Using Bhabha and digamma events, we measure the integrated luminosity of the data sample to be (, where the first uncertainty is statistical and the second is systematic. This work provides a basis for future luminosity measurements at Belle II. | Abudinen, F.; Adachi, I; Ahlburg, P.; Aihara, H.; Akopov, N.; Aloisio, A.; Ameli, F.; Andricek, L.; Ky, N. Anh; Asner, D. M.; Atmacan, H.; Aushev, T.; Aushev, V; Aziz, T.; Azmi, K.; Babu, V; Baehr, S.; Bahinipati, S.; Bakich, A. M.; Bambade, P.; Banerjee, Sw; Bansal, S.; Bansal, V; Barrett, M.; Baudot, J.; Beaulieu, A.; Becker, J.; Behera, P. K.; Bennett, J., V; Bernieri, E.; Bernlochner, F. U.; Bertemes, M.; Bessner, M.; Bettarini, S.; Bhardwaj, V; Bianchi, F.; Bilka, T.; Bilokin, S.; Biswas, D.; Bonvicini, G.; Bozek, A.; Bracko, M.; Branchini, P.; Braun, N.; Browder, T. E.; Budano, A.; Bussino, S.; Campajola, M.; Cao, L.; Casarosa, G.; Cecchi, C.; Cervenkov, D.; Chang, M-C; Chang, P.; Cheaib, R.; Chekelian, V; Chen, Y. Q.; Chen, Y-T; Cheon, B. G.; Chilikin, K.; Cho, H-E; Cho, K.; Cho, S.; Choi, S-K; Choudhury, S.; Cinabro, D.; Corona, L.; Cremaldi, L. M.; Cunliffe, S.; Czank, T.; Dattola, F.; De La Cruz-Burelo, E.; De Nardo, G.; De Nuccio, M.; De Pietro, G.; de Sangro, R.; Destefanis, M.; Dey, S.; De Yta-Hernandez, A.; Di Capua, F.; Di Carlo, S.; Dingfelder, J.; Dolezal, Z.; Dominguez Jimenez, I; Dong, T., V; Dort, K.; Dubey, S.; Duell, S.; Eidelman, S.; Eliachevitch, M.; Ferber, T.; Ferlewicz, D.; Finocchiaro, G.; Fiore, S.; Fodor, A.; Forti, F.; Frey, A.; Fulsom, B. G.; Gabriel, M.; Ganiev, E.; Garcia-Hernandez, M.; Garg, R.; Garmash, A.; Gaur, V; Gaz, A.; Gebauer, U.; Gellrich, A.; Gemmler, J.; Gessler, T.; Giordano, R.; Giri, A.; Gobbo, B.; Godang, R.; Goldenzweig, P.; Golob, B.; Gomis, P.; Grace, P.; Gradl, W.; Graziani, E.; Greenwald, D.; Hadjivasiliou, C.; Halder, S.; Hara, K.; Hara, T.; Hartbrich, O.; Hayasaka, K.; Hayashii, H.; Hearty, C.; Hedges, M. T.; Heredia de la Cruz, I; Villanueva, M. Hernandez; Hershenhorn, A.; Higuchi, T.; Hill, E. C.; Hirata, H.; Hoek, M.; Hollitt, S.; Hotta, T.; Hsu, C-L; Hu, Y.; Huang, K.; Iijima, T.; Inami, K.; Inguglia, G.; Jabbar, J. Irakkathil; Ishikawa, A.; Itoh, R.; Iwasaki, M.; Iwasaki, Y.; Iwata, S.; Jackson, P.; Jacobs, W. W.; Jaffe, D. E.; Jang, E-J; Jeon, H. B.; Jia, S.; Jin, Y.; Joo, C.; Kahn, J.; Kakuno, H.; Kaliyar, A. B.; Karyan, G.; Kato, Y.; Kawasaki, T.; Kichimi, H.; Kiesling, C.; Kim, B. H.; Kim, C-H; Kim, D. Y.; Kim, S-H; Kim, Y. K.; Kim, Y.; Kimmel, T. D.; Kinoshita, K.; Kleinwort, C.; Knysh, B.; Kodys, P.; Koga, T.; Komarov, I; Konno, T.; Korpar, S.; Kotchetkov, D.; Kovalchuk, N.; Kraetzschmar, T. M. G.; Krizan, P.; Kroeger, R.; Krohn, J. F.; Krokovny, P.; Kuehn, W.; Kuhr, T.; Kumar, M.; Kumar, R.; Kumara, K.; Kurz, S.; Kuzmin, A.; Kwon, Y-J; Lacaprara, S.; Lai, Y-T; La Licata, C.; Lalwani, K.; Lanceri, L.; Lange, J. S.; Lautenbach, K.; Lee, I-S; Lee, S. C.; Leitl, P.; Levit, D.; Lewis, P. M.; Li, C.; Li, L. K.; Li, S. X.; Li, Y. M.; Li, Y. B.; Libby, J.; Lieret, K.; Li Gioi, L.; Lin, J.; Liptak, Z.; Liu, Q. Y.; Liventsev, D.; Longo, S.; Loos, A.; Luetticke, F.; Luo, T.; MacQueen, C.; Maeda, Y.; Maggiora, M.; Maity, S.; Manoni, E.; Marcello, S.; Marinas, C.; Martini, A.; Masuda, M.; Matsuoka, K.; Matvienko, D.; McNeil, J.; Mei, J. C.; Meier, F.; Merola, M.; Metzner, F.; Milesi, M.; Miller, C.; Miyabayashi, K.; Miyata, H.; Mizuk, R.; Mohanty, G. B.; Moon, H.; Morii, T.; Moser, H-G; Mueller, F.; Mueller, F. J.; Muller, Th; Mussa, R.; Nakamura, K. R.; Nakano, E.; Nakao, M.; Nakayama, H.; Nakazawa, H.; Nayak, M.; Nazaryan, G.; Neverov, D.; Niiyama, M.; Nisar, N. K.; Nishida, S.; Nishimura, K.; Nishimura, M.; Nouxman, M. H. A.; Oberhof, B.; Ogawa, S.; Onishchuk, Y.; Ono, H.; Onuki, Y.; Oskin, P.; Ozaki, H.; Pakhlov, P.; Pakhlova, G.; Paladino, A.; Pang, T.; Paoloni, E.; Park, H.; Park, S-H; Paschen, B.; Passeri, A.; Patra, S.; Paul, S.; Pedlar, T. K.; Peruzzi, I; Peschke, R.; Pestotnik, R.; Piccolo, M.; Piilonen, L. E.; Podesta-Lerma, P. L. M.; Popov, V; Praz, C.; Prencipe, E.; Prim, M. T.; Purohit, M., V; Rados, P.; Remnev, M.; Resmi, P. K.; Ripp-Baudot, I; Ritter, M.; Ritzert, M.; Rizzo, G.; Rizzuto, L. B.; Robertson, S. H.; Rodriguez Perez, D.; Roney, J. M.; Rosenfeld, C.; Rostomyan, A.; Rout, N.; Russo, G.; Sahoo, D.; Sakai, Y.; Sanders, D. A.; Sandilya, S.; Sangal, A.; Santelj, L.; Sartori, P.; Sato, Y.; Savinov, V; Scavino, B.; Schram, M.; Schreeck, H.; Schueler, J.; Schwanda, C.; Schwartz, A. J.; Schwenker, B.; Seddon, R. M.; Seino, Y.; Selce, A.; Senyo, K.; Sevior, M. E.; Sfienti, C.; Shen, C. P.; Shibuya, H.; Shiu, J-G; Sibidanov, A.; Simon, F.; Skambraks, S.; Sobie, R. J.; Soffer, A.; Sokolov, A.; Solovieva, E.; Spataro, S.; Spruck, B.; Staric, M.; Stefkova, S.; Stottler, Z. S.; Stroili, R.; Strube, J.; Sumihama, M.; Sumiyoshi, T.; Summers, D. J.; Sutcliffe, W.; Tabata, M.; Takizawa, M.; Tamponi, U.; Tanaka, S.; Tanida, K.; Tanigawa, H.; Taniguchi, N.; Tao, Y.; Taras, P.; Tenchini, F.; Torassa, E.; Trabelsi, K.; Tsuboyama, T.; Tsuzuki, N.; Uchida, M.; Ueda, I; Uehara, S.; Uglov, T.; Unger, K.; Unno, Y.; Uno, S.; Urquijo, P.; Ushiroda, Y.; Vahsen, S. E.; van Tonder, R.; Varner, G. S.; Varvell, K. E.; Vinokurova, A.; Vitale, L.; Vossen, A.; Waheed, E.; Wakeling, H. M.; Wan, K.; Abdullah, W. Wan; Wang, B.; Wang, M-Z; Wang, X. L.; Warburton, A.; Watanabe, M.; Watanuki, S.; Webb, J.; Wehle, S.; Wermes, N.; Wessel, C.; Wiechczynski, J.; Wieduwilt, P.; Windel, H.; Won, E.; Yamada, S.; Yan, W.; Yang, S. B.; Ye, H.; Yelton, J.; Yin, J. H.; Yonenaga, M.; Yook, Y. M.; Yuan, C. Z.; Yusa, Y.; Zani, L.; Zhang, J. Z.; Zhang, Z.; Zhilich, V; Zhou, Q. D.; Zhou, X. Y.; Zhukova, V., I; Zhulanov, V; Zupanc, A. | Beihang Univ, Beijing 100191, Peoples R China; Brookhaven Natl Lab, Upton, NY 11973 USA; Budker Inst Nucl Phys SB RAS, Novosibirsk 630090, Russia; Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Mexico City 07360, DF, Mexico; Charles Univ Prague, Fac Math & Phys, CR-12116 Prague, Czech Republic; Chiba Univ, Chiba 2638522, Japan; Consejo Nacl Ciencia & Technol, Mexico City 03940, DF, Mexico; DESY, D-22607 Hamburg, Germany; Duke Univ, Durham, NC 27708 USA; Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan; Forschungszentrum Julich, D-52425 Julich, Germany; Fu Jen Catholic Univ, Dept Phys, Taipei 24205, Taiwan; Fudan Univ, Key Lab Nucl Phys & Ion Beam Applicat MOE, Shanghai 200443, Peoples R China; Fudan Univ, Inst Modern Phys, Shanghai 200443, Peoples R China; Georg August Univ Gottingen, Phys Inst 2, D-37073 Gottingen, Germany; Gifu Univ, Gifu 5011193, Japan; Grad Univ Adv Studies SOKENDAI, Hayama, Kanagawa 2400193, Japan; Gyeongsang Natl Univ, Jinju 52828, South Korea; Hanyang Univ, Dept Phys, Seoul 04763, South Korea; Hanyang Univ, Inst Nat Sci, Seoul 04763, South Korea; High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki 3050801, Japan; High Energy Accelerator Res Org, Theory Ctr, KEK, J PARC Branch, Tsukuba, Ibaraki 3050801, Japan; Indian Inst Sci Educ & Res Mohali, Sas Nagar 140306, India; Indian Inst Technol Bhubaneswar, Satya Nagar 751007, India; Indian Inst Technol Hyderabad, Hyderabad 502285, Telangana, India; Indian Inst Technol Madras, Chennai 600036, Tamil Nadu, India; Indiana Univ, Bloomington, IN 47408 USA; Inst High Energy Phys, Protvino 142281, Russia; Inst High Energy Phys, A-1050 Vienna, Austria; Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China; Inst Particle Phys Canada, Victoria, BC V8W 2Y2, Canada; Inst Phys, Hanoi, Vietnam; Inst Fis Corpuscular, I-46980 Paterna, Italy; INFN, Lab Nazl Frascati, I-00044 Frascati, Italy; INFN, Sez Napoli, I-80126 Naples, Italy; INFN, Sez Padova, I-35131 Padua, Italy; INFN, Sez Perugia, I-06123 Perugia, Italy; INFN, Sez Pisa, I-56127 Pisa, Italy; INFN, Sez Roma, I-00185 Rome, Italy; INFN, Sez Roma Tre, I-00146 Rome, Italy; INFN, Sez Torino, I-10125 Turin, Italy; INFN, Sez Trieste, I-34127 Trieste, Italy; Japan Atom Energy Agcy, Adv Sci Res Ctr, Naka, Ibaraki 3191195, Japan; Johannes Gutenberg Univ Mainz, Inst Kernphys, D-55099 Mainz, Germany; Justus Liebig Univ Giessen, D-35392 Giessen, Germany; Karlsruher Inst Technol, Inst Expt Teilchenphys, D-76131 Karlsruhe, Germany; Kitasato Univ, Sagamihara, Kanagawa 2520373, Japan; Korea Inst Sci & Technol Informat, Daejeon 34141, South Korea; Korea Univ, Seoul 02841, South Korea; Kyoto Sangyo Univ, Kyoto 6038555, Japan; Kyungpook Natl Univ, Daegu 41566, South Korea; CNRS, Lab Accelerateur Lineaire, IN2P3, F-91898 Orsay, France; Univ Paris Sud 11, Ctr Sci Orsay, F-91898 Orsay, France; Russian Acad Sci, PN Lebedev Phys Inst, Moscow 119991, Russia; Liaoning Normal Univ, Dalian 116029, Peoples R China; Ludwig Maximilians Univ Munchen, D-80539 Munich, Germany; Luther Coll, Decorah, IA 52101 USA; Malaviya Natl Inst Technol Jaipur, Jaipur 302017, Rajasthan, India; Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; Max Planck Gesell, Semicond Lab, D-81739 Munich, Germany; McGill Univ, Montreal, PQ H3A 2T8, Canada; Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; Moscow Phys Engn Inst, Moscow 115409, Russia; Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Kobayashi Maskawa Inst, Nagoya, Aichi 4648602, Japan; Nara Womens Univ, Nara 6308506, Japan; Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan; H Niewodniczanski Inst Nucl Phys, PL-31342 Krakow, Poland; Niigata Univ, Niigata 9502181, Japan; Novosibirsk State Univ, Novosibirsk 630090, Russia; Okinawa Inst Sci & Technol, Onna, Okinawa 9040495, Japan; Osaka City Univ, Osaka 5588585, Japan; Osaka Univ, Res Ctr Nucl Phys, Osaka 5670047, Japan; Pacific Northwest Natl Lab, Richland, WA 99352 USA; Panjab Univ, Chandigarh 160014, India; Peking Univ, Beijing 100871, Peoples R China; Punjab Agr Univ, Ludhiana 141004, Punjab, India; RIKEN, Theoret Res Div, Nishina Ctr, Wako, Saitama 3510198, Japan; Seoul Natl Univ, Seoul 08826, South Korea; Showa Pharmaceut Univ, Tokyo 1948543, Japan; Soongsil Univ, Seoul 06978, South Korea; J Stefan Inst, Ljubljana 1000, Slovenia; Taras Shevchenko Natl Univ Kiev, Kiev, Ukraine; Tata Inst Fundamental Res, Mumbai 400005, Maharashtra, India; Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; Toho Univ, Funabashi, Chiba 2748510, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; Tokyo Inst Technol, Tokyo 1528550, Japan; Tokyo Metropolitan Univ, Tokyo 1920397, Japan; Univ Autonoma Sinaloa, Culiacan 80000, Sinaloa, Mexico; Univ Napoli Federico II, Dipartimento Sci Fis, I-80126 Naples, Italy; Univ Napoli Federico II, Dipartimento Agr, I-80055 Portici, NA, Italy; Univ Padua, Dipartimento Fis & Astron, I-35131 Padua, Italy; Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; Univ Pisa, Dipartimento Fis, I-56127 Pisa, Italy; Univ Roma Tre, Dipartimento Matemat & Fis, I-00146 Rome, Italy; Univ Torino, Dipartimento Fis, I-10125 Turin, Italy; Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; Univ Montreal, Phys Particules, Montreal, PQ H3C 3J7, Canada; Univ Strasbourg, IPHC, CNRS, UMR 7178, F-67037 Strasbourg, France; Univ Adelaide, Dept Phys, Adelaide, SA 5005, Australia; Univ Bonn, D-53115 Bonn, Germany; Univ British Columbia, Vancouver, BC V6T 1Z1, Canada; Univ Cincinnati, Cincinnati, OH 45221 USA; Univ Florida, Gainesville, FL 32611 USA; Univ Hawaii, Honolulu, HI 96822 USA; Heidelberg Univ, D-68131 Mannheim, Germany; Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; Univ Louisville, Louisville, KY 40292 USA; Univ Malaya, Natl Ctr Particle Phys, Kuala Lumpur 50603, Malaysia; Univ Maribor, SLO-2000 Maribor, Slovenia; Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia; Univ Mississippi, University, MS 38677 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Univ Sci & Technol China, Hefei 230026, Peoples R China; Univ S Alabama, Mobile, AL 36688 USA; Univ South Carolina, Columbia, SC 29208 USA; Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; Univ Victoria, Victoria, BC V8W 3P6, Canada; Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; Wayne State Univ, Detroit, MI 48202 USA; Yamagata Univ, Yamagata 9908560, Japan; Alikhanyan Natl Sci Lab, Yerevan 0036, Armenia; Yonsei Univ, Seoul 03722, South Korea | Zhukova, Valentina/C-8878-2016; Li, Longke/MSZ-3796-2025; branchini, paolo/A-4857-2011; Pang, Peter Tsun Ho/JCD-5182-2023; Kuzmin, Alexander/AAR-8369-2021; Passeri, Antonio/AAJ-8429-2020; Nellikunnummel, Nisar/AAY-7200-2021; Fiori, Francesco/H-1454-2018; Strube, Jan/T-6675-2019; Pestotnik, Rok/A-3626-2008; Solovieva, Elena/B-2449-2014; LIPTAK, ZACHARY/AAR-3980-2020; Won, Eunil/S-7182-2019; Strube, Jan/E-9310-2015; Giordano, Raffaele/J-3695-2012; Rizzo, Giuliana/A-8516-2015; Hotta, Tomoaki/AAQ-2298-2020; wang, xiang/IVV-6713-2023; Forti, Francesco/H-3035-2011; Dong, Thanh/MIT-2305-2025; De La Cruz Burelo, Eduard/AAR-9103-2021; Liventsev, Dmitri/MYR-0735-2025; lu, Li/KBA-2603-2024; Kumar, Abhishek/KCL-4676-2024; Waheed, Eiasha/AAG-6743-2021; Egorychev, Victor/H-1076-2014; Cervenkov, Daniel/D-2884-2017; Kumar, Rajender/JSL-0696-2023; Chang, Philip/AAN-3350-2021; Torassa, Ezio/I-1788-2012; Gradl, Wolfgang/L-9244-2018; Tamponi, Umberto/AGG-5576-2022; Doležal, Zdeněk/K-6861-2017; Kim, Soo-Bong/B-7061-2014; Onishchuk, Yuriy/AAS-8411-2020; Sumiyoshi, Takayuki/Q-5536-2017; Kim, Ji/AAU-5043-2020; Cheaib, Racha/G-5301-2019; Sandilya, Saurabh/AAR-2477-2021; Gaur, Vipin/HZM-4280-2023; Moon, Hyun June/NKP-8678-2025; Müller, Fabian/AEW-8288-2022; kim, sang-soo/C-6573-2009; Tenchini, Francesco/JTT-8673-2023; Pachariya, Manoj/A-9646-2016; Niiyama, Masayuki/HPE-8084-2023; Zhang, Zhenyu/AAC-8636-2022; Lewis, Phillip/KLD-0569-2024; Zhou, Xiao-Yu/B-2593-2018; Bilka, Tadeáš/Q-3680-2017; Yan, Weichao/JDC-8711-2023; Maggiora, Marco/D-4627-2011; BABU, JENSY/KAM-3345-2024; Natkaniec, Zbigniew/AAP-2995-2021; Kodys, Peter/P-2636-2017; Banerjee, Swagato/AAN-3326-2021; Pakhlov, Pavel/K-2158-2013; Pakhlova, Galina/C-5378-2014; ISHIKAWA, Akimasa/AAG-9668-2020; Zhou, Qidong/KUF-4361-2024; Cheon, Byung/B-3035-2008; Behera, Prafulla/AAK-8686-2020; Aushev, Tagir/AAN-9735-2020; Liptak, Zachary/AAR-3980-2020; Li, Jiarong/ABG-6750-2022; Uglov, Timofey/B-2406-2014; Krokovny, Pavel/G-4421-2016; Iwasaki, Masako/AAG-6574-2019; Mizuk, Roman/B-3751-2014; Iijima, Toru/LNR-4469-2024; Choudhury, Seema/LEM-7962-2024; de Sangro, Riccardo/J-2901-2012; , Luo/AAP-8401-2020; Zhang, Yang/AAI-5293-2020; Dominguez, Isabel/AAR-1744-2021; Bhardwaj, Vishal/JXN-3575-2024; Oskin, Pavel/AAB-5345-2020; Llácer, María/AAQ-7522-2020; Rossi, Eleonora/JYO-6120-2024; Remnev, Mikhail/M-9128-2018; Bilka, Tadeas/Q-3680-2017; bettarini, stefano/M-2502-2016; de pietro, giuseppe/L-6139-2019; Chilikin, Kirill/B-4402-2014; Campajola, Marcello/V-1689-2019; Spataro, Stefano/E-1305-2012; Paul, Stephan/F-7596-2015; Marinas, Carlos/AAB-9328-2021; Chen, Ziqi/HPE-6145-2023; Levit, Dmytro/HGE-7841-2022; Li, Chun/KBC-9591-2024; Warburton, Andreas/N-8028-2013; Kim, Ji Hoon/AAB-4602-2022; Joo, Changwoo/ABI-4034-2020; Aushev, Volodymyr/AAS-8421-2020; Heredia De La Cruz, Ivan/L-2610-2018; Aihara, Hiroaki/F-3854-2010; akma, khasmi/HQY-1190-2023 | 56712971200; 35226935400; 57203886109; 26431253400; 7004430681; 55667348900; 7004440709; 8121374400; 6507592933; 35226924300; 35228789100; 35226925000; 6602773267; 57198200847; 57215875116; 56673779100; 56451002200; 35226929900; 56431278900; 8777647300; 57220783260; 57189457515; 36553879600; 55329449900; 7003306478; 55878146300; 55842468000; 57943353600; 35313360100; 23020654600; 35228802000; 57216645450; 57208362193; 55116333600; 22233547600; 59832955200; 56624583600; 56938966300; 58948022700; 57206506584; 57225386308; 35271332600; 7007185851; 57195483486; 35226974400; 35276918200; 7004000387; 57201115046; 57204568429; 36169158700; 35227087600; 55913471500; 35225729000; 55628577865; 55196023400; 8062452000; 57202255255; 56783542800; 35271166300; 57225375986; 57207576178; 57207798241; 57216645386; 35227095000; 57767118500; 57215682164; 57209105515; 35271811200; 55368264400; 57028463700; 57216644248; 56000744300; 35227136100; 57203807007; 57206305017; 35227135100; 57265688200; 56151129600; 56224175000; 57208830718; 57190000762; 35227134400; 57214699347; 57189841299; 57488886000; 57210733619; 56044932800; 57195154740; 34970948300; 57191828142; 15126870300; 57211204300; 35227148700; 35227210000; 57214231768; 35227146800; 34569178400; 35227244500; 54973551200; 57215857442; 57216643642; 55452240700; 35227285100; 37074665000; 57216904183; 57203882898; 56237831600; 57195485997; 54380023800; 35240421200; 7102961266; 35227306900; 55158709500; 35233679700; 35227277400; 57200973501; 57216819307; 57202563302; 7006321472; 57000100700; 15848423500; 57209094410; 57205557485; 7404213171; 55816086100; 35227356500; 35227353100; 35272292500; 15925464600; 56561950900; 57190214442; 57207898928; 57224139534; 35227380300; 57208334559; 9842870100; 55318835700; 8896326100; 55817230300; 56449532000; 55277134500; 56411594700; 56522611500; 54881461100; 57216645018; 35227389900; 7103061159; 35227405400; 56522275200; 57206217172; 57724141800; 7201781287; 35227377500; 57212275346; 57014196800; 57194692653; 59299091500; 54398896700; 57196259512; 57212671447; 57193274163; 35221743200; 57205380997; 35227364200; 35227523300; 8062452400; 59789719000; 57221217066; 35225891500; 7601588326; 59734007100; 59621542900; 57211428599; 35227494800; 7004135079; 57216825886; 14826956800; 56591531700; 57203089210; 53063887800; 57080476200; 8415873500; 55696385800; 57199166702; 10639485800; 35227502900; 57204506375; 57208069443; 7202988771; 35227570700; 57221404520; 57203774559; 57216645334; 57189263009; 57205335932; 56419217900; 6602154453; 56085986100; 55759603000; 46661127500; 57211953490; 56812501100; 56613894500; 55816685400; 57257924100; 57203892660; 55634685800; 7402868981; 36065449800; 57202345327; 58817364400; 58119320500; 58754147400; 55820982400; 57211034012; 26867892800; 55531231600; 48261344700; 57385817000; 56812540000; 56465149500; 57188693875; 57215326675; 36777886700; 57205390925; 57203538981; 7003691265; 57220731521; 35230473900; 57670464300; 26538756000; 57204078384; 56779517600; 57222813844; 18536939900; 57197157079; 57216644943; 36699978600; 36876647700; 57195488802; 55405221400; 57223828952; 56235238900; 57219755059; 35227750200; 35227732200; 56542409600; 57014635700; 35314973000; 55046963200; 24781054800; 56597596100; 55406048600; 56394864900; 56450249700; 57203524033; 58825411600; 56522396400; 55631815900; 57210153514; 57208336599; 57219719005; 55632289100; 35227758100; 26632346500; 57216645406; 56267050700; 57213829977; 35227762800; 55928400000; 7401965457; 35227766800; 57211715084; 55627873885; 35227740400; 35234620700; 56572518100; 57211082131; 35227715200; 35086680500; 57207467557; 57015269000; 23025523000; 57219437245; 7401979314; 35227847800; 35227861400; 56070024500; 35227892100; 35227844100; 57205388346; 35227860100; 58918272500; 57216644153; 35227850000; 36099403700; 35227838600; 56045674100; 57219793453; 57200576462; 35227855600; 22968787800; 23480300600; 35227845800; 57215858167; 35227848400; 57197768427; 34573306300; 7103362593; 8721811800; 57213625981; 7202429853; 57215857178; 7403480472; 35227953000; 56985930800; 57215862663; 35590850800; 7006390180; 56650391100; 56482852900; 57203884521; 35230861800; 57203884301; 57204956418; 35228014600; 57775849100; 37095970500; 57201450334; 56985327200; 57193662534; 57214214242; 35227980100; 6603486370; 35227999800; 57202334469; 55628572552; 6701391049; 55627811900; 56712869800; 35227957300; 34769039700; 57212378611; 25958374200; 57194602095; 15840433100; 35227948400; 56786375800; 57204951723; 35228072000; 35228087500; 6603406495; 55554740400; 57216232195; 55913607000; 57189069907; 35942976800; 56808198900; 57232742000; 8388152800; 57203804357; 55286808700; 57207868018; 35228064300; 37103051300; 57210385511; 35228062300; 16020533400; 57200529172; 56388230800; 57203905010; 35228144200; 35228072600; 57215131426; 59828691600; 35228086800; 35228106200; 35228137800; 36154061900; 57204557858; 35228075800; 35228095700; 35273620100; 57198320699; 36934412800; 57193702443; 57215861826; 57195153044; 57200995101; 57758561300; 35228078700; 59357906600; 35228216200; 35228289800; 57014809700; 57014140800; 56453244800; 8903094300; 57194827851; 15835927600; 57192433759; 57194599647; 35274124300; 58734248100; 35770088900; 57204951807; 55286044100; 57202448079; 59213845500; 57193333004; 55770777700; 34882495500; 55145482100; 57195150092; 57834545900; 58754347000; 35228211600; 56718893900; 57817715200; 57990888000; 35273950000; 35228292000 | CHINESE PHYSICS C | CHINESE PHYS C | 1674-1137 | 2058-6132 | 44 | 2 | SCIE | PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS | 2020 | 2.145 | 44.7 | 1.97 | 2025-06-25 | 32 | 37 | luminosity; Bhabha; digamma; Belle II | LOWEST-ORDER CALCULATIONS; FINAL-STATES; SIMULATION; PRECISION | Belle II; Bhabha; digamma; luminosity | English | 2020 | 2020-02 | 10.1088/1674-1137/44/2/021001 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Quenching of γ0 transition results from 2p-1h doorway mechanism by p-wave neutron excitation | The ratio of gamma transition-intensities from the initial capture state to low-lying states may represent the model-independent gamma-strength function, which reflects the effects of different neutron-capture reaction mechanisms. The extraordinary quenching of the gamma(0) transition from the p-wave neutron radiative capture in Fe-57 is observed, for the first time, from the pronounced enhancement of the gamma-strength function ratios f(gamma 1)/f(gamma 0) and f(gamma 2)/f(gamma 0). The 2p-1h doorway excitation leads to suppression of the gamma(0) transition to the ground state and the enhancement of the gamma(1) and gamma(2) transitions to the first and second excited states, respectively. The sub-shells supply the exact number of spaces required for the 2p-1h configuration, which features the neutron capture mechanism in the vicinity of A = 55. | Wang, Tao-Feng; Yang, Xiao-Ting; Katabuchi, T.; Li, Zi-Ming; Xu, Zhi-Bo; Kim, G. N.; Ro, T. I.; Han, Ying-Lu; Zhu, Li-Hua; Igashira, M. | Beihang Univ, Sch Phys, Beijing 100191, Peoples R China; Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing 100191, Peoples R China; Kyungpook Natl Univ, Dept Phys, Daegu 702701, South Korea; Dong A Univ, Dept Phys, Busan 604714, South Korea; China Inst Atom Energy, Beijing 102413, Peoples R China; Tokyo Inst Technol, Nucl Reactors Res Lab, Tokyo 1528550, Japan; Chongqing Jianan Instrument Co LTD, Chongqing 400060, Peoples R China | Katabuchi, Tatsuya/C-6940-2015; Li, Zi-Ming/ABC-4297-2021 | 56135285000; 57216750977; 23392432900; 57298410000; 57219285339; 35313854400; 56236657700; 57219289113; 58257788300; 22961715700 | gnkim@knu.ac.kr; | CHINESE PHYSICS C | CHINESE PHYS C | 1674-1137 | 2058-6132 | 44 | 10 | SCIE | PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS | 2020 | 2.145 | 44.7 | 0 | 2025-06-25 | 0 | 0 | neutron capture; nuclear decay; nuclear structure | RADIATIVE-CAPTURE; CODE | neutron capture; nuclear decay; nuclear structure | English | 2020 | 2020-10 | 10.1088/1674-1137/abab8b | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Estimation of High-Frequency Spectral Decay (κ) for the Gyeongju Area in South Korea | The high-frequency spectral decay parameter kappa (kappa) is estimated for the Gyeongju area using records of the temporary seismic array in the Gyeongju area (TSAG), which operated from 2010 to 2013. Gyeongju is a city located in the southeastern part of the Korean Peninsula. Moderate earthquakes frequently occurred around the Gyeongju area in the past; the area has experienced numerous earthquakes for more than a year since an earthquake of M-L 5.8 occurred in Gyeongju on 12 September 2016. It is also an important place from an engineering point of view because nuclear facilities are located in the area. The high-frequency spectral decay model of Anderson and Hough (1984) and the standardized procedure for the x-estimation suggested by Ktenidou et al. (2013) are applied to estimate kappa for the Gyeongju area. The estimation gives rise to the equation, kappa = 0.0219(+/- 0.00151)+7.56 x 10(-5) (+/- 1.45 x 10(-5))R indicating that the site-specific kappa(0)-value and the slope kappa(R) are 0.0219 s and 7.56 x 10(-5) s/km, respectively, for the Gyeongju area. The kappa-estimation for individual stations of TSAG was done to obtain the site-specific kappa(0)-values of stations. Despite the close distance between TSAG stations, the site-specific kappa(0)-values of each station vary. Other than TSAG, kappa is also estimated for the permanent borehole station HDB, which has been operated by the Korea Institute of Geoscience and Mineral Resources and is located in the Gyeongju area. The estimated kappa(0)-value of 0.0178 s for HDB is smaller than that of TSAG by 0.0219 s. This is because HDB is a borehole station, but all stations of TSAG are installed at surface. The variation of the kappa(0)-values among the individual TSAG stations and the difference between kappa(0) for TSAG and that for HDB indicate that spectral decay characteristic at high frequency is affected by surficial sediment layers. | Park, Seon Jeong; Lee, Jung Mo; Baag, Chang-Eob | Korea Inst Nucl Safety, Daejeon, South Korea; Kyungpook Natl Univ, Sch Earth Syst Sci, Daegu, South Korea; Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea | 24464007100; 36020357100; 6602456632 | jung@knu.ac.kr; | BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA | B SEISMOL SOC AM | 0037-1106 | 1943-3573 | 110 | 1 | SCIE | GEOCHEMISTRY & GEOPHYSICS | 2020 | 2.91 | 44.9 | 0.19 | 2025-06-25 | 5 | 3 | EARTHQUAKE GROUND MOTIONS; NEAR-SURFACE ATTENUATION; HARD-ROCK; MODEL; SIMULATION; BOREHOLE; SHAPE | Gyeongju; North Kyongsang; South Korea; Boreholes; Earthquakes; Mineral resources; Surficial sediments; Borehole stations; High frequency HF; Nuclear facilities; Seismic arrays; Site-specific; South Korea; Spectral decay; Standardized procedure; earthquake; estimation method; spectral analysis; surficial sediment; Frequency estimation | English | 2020 | 2020-02 | 10.1785/0120180345 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||||
| ○ | ○ | Article | Health-Related Quality of Life in Older Adults: Its Association with Health Literacy, Self-Efficacy, Social Support, and Health-Promoting Behavior | This cross-sectional study aimed to explore the relationships among sociodemographics, health literacy, self-efficacy, social support, health-promoting behavior, and health-related quality of life (HRQOL) in older adults. A total of 240 older adults aged >65 years were recruited from three community senior welfare centers in South Korea. Standardized self-administered questionnaires measuring sociodemographic characteristics, health literacy, social support, self-efficacy, health-promoting behavior, and health-related quality of life were distributed to older adults. Multiple regression analyses with stepwise selection was used to determine the factors affecting health-related quality of life. Factors affecting a higher physical component score of HRQOL were a higher comprehension level of and numeracy in health literacy, physical health-promoting behavior, perceived emotional-informational support, and a lesser number of comorbidities. Factors affecting a higher mental component score of HRQOL were a higher comprehension level of and numeracy in health literacy, self-efficacy, physical health-promoting behavior, perceived emotional-informational support, and a lesser number of comorbidities. To improve HRQOL among older adults, nursing interventions are required to measure health literacy, empower physical health-promoting behavior and self-efficacy, and enhance emotional-informational support from family or other resources. | Lee, Myung Kyung; Oh, Jihyun | Kyungpook Natl Univ, Res Inst Nursing Sci, Coll Nursing, Daegu 41944, South Korea; Daejeon Univ, Dept Nursing, Daejeon 34520, South Korea | 40661513200; 57207574572 | mlee@knu.ac.kr;jihy0123@dju.kr; | HEALTHCARE | HEALTHCARE-BASEL | 2227-9032 | 8 | 4 | SCIE;SSCI | HEALTH CARE SCIENCES & SERVICES;HEALTH POLICY & SERVICES | 2020 | 2.645 | 44.9 | 4.74 | 2025-06-25 | 87 | 105 | health literacy; self-efficacy; social support; health-promoting behavior; quality of life | FAMILY CAREGIVERS; PHYSICAL HEALTH; SHORT-FORM; PEOPLE; DISTRESS; SCALE; PAIN | Health literacy; Health-promoting behavior; Quality of life; Self-efficacy; Social support | English | 2020 | 2020-12 | 10.3390/healthcare8040407 | 바로가기 | 바로가기 | 바로가기 | 바로가기 |
페이지 이동: